White Papers

1. Flying On Two Wings: Balancing Local Agility And Global Quality In China 8/12/2026

   As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.

2. Matching Pharmacovigilance Methodology To Organizational Scale 8/12/2026

   One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.

3. The Engagement Equation: Collaborate To Improve The Patient Experience 8/8/2026

   Fragmented trial operations trigger costly enrollment delays. Discover how operational alignment among sponsors, CROs, and site networks drives patient retention and study success.

4. Redefining Vaccine Trial Recruitment 8/8/2026

   Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.

5. Overcoming Obesity Trial's Patient Engagement And Retention Challenges 8/8/2026

   Extended obesity trials often face high dropout rates due to fatigue and strict protocols. Learn how personalized engagement and strong care relationships improve participant retention.

6. The Renaissance Of Psychedelic Research: History, Protocols, And Forward Trajectories 7/30/2026

   Discover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.

7. UK Clinical Trial Regulations Reform 7/24/2026

   UK trial regulations have been overhauled. Learn what faster approval pathways, stricter publication rules, and longer retention requirements mean for your operations.

8. ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials 7/24/2026

   Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.

9. Five Preventable Clinical Design Pitfalls And How To Avoid Them 7/21/2026

   While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.

10. Busy Quarter For Gene, Cell, RNA Therapies 7/21/2026

    Explore how Q2 brought renewed momentum for gene, cell, and RNA therapies and grew confidence in the future of advanced medicine with rising approvals, expanding pipelines, and increased investment.